APBI 2016

First page Previous page 118 Next page Last page

Background: Interaction S and LR treatments

1/1.5

1/4

1/2-3

1/4

1/ ∞

Poortmans P. Lancet. 2014 Jun 21;383(9935):2104-6.

Made with